Syneos Health (NASDAQ:SYNH) is up 5% premarket on light volume in reaction to its disclosure that the SEC has completed its investigation, started in February, into its revenue accounting policies, internal controls and related matters. The regulator will take no enforcement action.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.